Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future? | Cancer J;27(2): 168-175, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future?

Ali, Alaa Kassim; Tarannum, Mubin; Romee, Rizwan.

Affiliation

Ali AK; From the Cellular Therapy and Stem Cell Transplant Program, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.

Cancer J ; 27(2): 168-175, 2021.

Article in En | MEDLINE | ID: mdl-33750077

Subject(s)

Immunotherapy, Adoptive; Neoplasms; Receptors, Chimeric Antigen; Humans; Immunotherapy, Adoptive/trends; Killer Cells, Natural; Macrophages; Natural Killer T-Cells; Neoplasms/therapy; Receptors, Chimeric Antigen/genetics; T-Lymphocytes

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Cancer J Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Morocco

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Cancer J Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Morocco